DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Smith I, Robertson J, Kilburn L. et al.
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.
Lancet Oncol 2020;
21: 1443-1454
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.